gastroparesis and glp 1 drugs GLP-1 receptor agonists delayed gastric emptying: implications for invasive cardiac interventions and surgery GLP-1 Genetics: How Genes Affect

Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy

Growing private healthcare expenditure and increasing physician adoption of advanced metabolic therapies continue to support market expansion

Retatrutide achieved up to 24.2% mean weight loss after 48 weeks in individuals with obesity and 16.9% in those with T2D after 36 weeks

What we know from phase 2 The 48-week phase 2 trial provided reassuring safety signals

Various dosages of Ozempic, Mounjaro, Wegovy and Saxenda comprised the seven most-searched drugs in our lookup tool

27 Subsequently, they investigated a triple agonist capable of simultaneously targeting the GLP-1R, the GCGR, and the GIPR